Get our introductory offer at only
$0
.99*/month
Cancel anytime
*$0.99/month for first 3 months
$29.90/month for the next 9 months
You are here
Biolidics launches IPO to raise S$6.1m
Ivan Lew, executive director and CEO of Biolidics, with the company's patented technology that can separate cancer cells from blood to test for the presence of cancer.
Singapore
MEDICAL technology company Biolidics on Tuesday launched an initial public offering (IPO) of 27.5 million new shares at S$0.28 each. The placement is in conjunction with its proposed listing on the Catalist board on Dec 19.
The shares will be placed out to retail and...
Please log in to continue reading.
